The mechanism likely involves slower nutrient absorption and stimulation of intestinal L-cells
When blood glucose levels are elevated, GLP-1 binding to beta-cell receptors triggers intracellular signaling cascades that enhance insulin synthesis and release

Symptoms may include decreased libido, erectile dysfunction, muscle loss, fatigue, and depressive feelings. Traditional testosterone replacement therapy (TRT) restores serum testosterone but suppresses FSH and LH, thereby inhibiting natural testosterone and sperm production. Enclomiphene, like CC, blocks estrogen receptors in the hypothalamus, preventing negative feedback and stimulating the release of FSH and LH. This boosts testosterone production in the testes, which also supports sperm production. Unlike zuclomiphene, enclomiphene acts as a pure estrogen antagonist, resulting in lower estrogen levels than CC but similar improvements in hypogonadal symptoms, with fewer estrogenic side effects. In one study, enclomiphene use in secondary hypogonadism was associated with an 80% reduction in adverse effects compared to CC. Clinical efficacy of enclomiphene Enclomiphene addresses the two hallmarks of secondary hypogonadism: low serum testosterone and low or inappropriately normal LH levels

Peptides are not a replacement for training fundamentals
GLP-1 + B12 GLP-1 + B12 combines GLP-1 support with Vitamin B12 to support metabolic health, appetite awareness, energy production, and overall wellness as part of a structured lifestyle routine